Icona Foundation Study Group Selected Research

HDL-triglyceride

1/2016

Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Icona Foundation Study Group Research Topics

Disease

2	Infections 12/2023 - 01/2017
2	Coinfection 12/2023 - 08/2009
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 03/2015
1	Liver Diseases (Liver Disease) 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023
1	Communicable Diseases (Infectious Diseases) 01/2020
1	HIV Infections (HIV Infection) 01/2018
1	Superinfection 04/2017
1	Diabetes Mellitus 01/2016
1	Lipodystrophy 09/2008

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2023
1	abacavir (Ziagen)FDA Link 01/2019
1	Antiviral Agents (Antivirals)IBA 04/2017
1	HDL-triglycerideIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	Transaminases (Aminotransferases)IBA 08/2009

Therapy/Procedure

2	Therapeutics 01/2017 - 03/2015
1	Transplantation 12/2023
1	Art Therapy 09/2008